Frances Borg

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

Trial of Tocilizumab in Giant-Cell Arteritis

Immune mechanisms in medium and large-vessel vasculitis

Clinical features of polymyalgia rheumatica and giant cell arteritis

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities

Design of the Tocilizumab in Giant Cell Arteritis Trial

Cardiovascular toxicities associated with immune checkpoint inhibitors

Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study.

Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series

Syndromes and complications of interferon therapy

BSR and BHPR guidelines for the management of polymyalgia rheumatica

BSR and BHPR guidelines for the management of giant cell arteritis

Neuro-ophthalmic complications in giant cell arteritis

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

Delays in recognition and management of giant cell arteritis: results from a retrospective audit

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis

9. Outcomes and cost effectiveness analysis of fast track pathway in giant cell arteritis